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Recently we discovered a previously uncharacterized gene with the
characteristics of a membrane progestin receptor (mPR) in a fish
model, spotted seatrout. Here, we report the identification, clon-
ing, and characteristics of other members of this hitherto unknown
family of putative mPRs from several vertebrate species, including
human, mouse, pig, Xenopus, zebrafish, and Fugu, with highly
conserved nucleotide and deduced amino acid sequences and
similar structures to the spotted seatrout mPR. The 13 vertebrate
genes identified seem to belong to an unknown gene family.
Phylogenetic analysis indicates these cDNAs comprise three dis-
tinct groups (named , , and ) within this gene family. Structural
analyses of the translated cDNAs suggest they encode membrane
proteins with seven transmembrane domains. The transcript sizes
of the human , , and  putative mPR mRNAs varied from 2.8 to
5.8 kb and showed distinct distributions in reproductive, neural,
kidney and intestinal tissues, respectively. Recombinant human ,
, and mouse  proteins produced in an Escherichia coli expression
system demonstrated high affinity (Kd  20–30 nM) saturable
binding for progesterone. Further analysis of binding to the -
subtype revealed binding was specific for progestins and was
displaceable, with rapid rates of association and dissociation (t1/2
2–8 min). These results suggest this is a new family of steroid
receptors unrelated to nuclear steroid receptors, but instead hav-
ing characteristics of G protein-coupled receptors.
A lthough the existence of specific receptors on the surface oftarget cells mediating rapid nongenomic actions of steroids
was recognized 20 years ago (1, 2), efforts to determine the
structures of steroid membrane receptors have been unsuccess-
ful until now (3–5). In the accompanying paper in this issue of
PNAS (6), we described a gene discovered in a teleost species,
spotted seatrout, whose protein fulfils the criteria for its desig-
nation as a steroid membrane receptor, including structural
plausibility, specific tissue and plasma membrane localization,
steroid binding characteristic of steroid and progestin receptors,
coupling to second messenger pathways, regulation by steroid
hormones, and biological relevance. Evidence was obtained that
this progestin membrane receptor (mPR) is the intermediary in
progestin induction of oocyte meiotic maturation in teleost fishes
and activates an inhibitory G protein (Gi/o), which suggests it may
be a G protein-coupled receptor (GPCR).
The aims of this study were to search for related cDNA
fragments of other vertebrates in the genomic databases, clone
and sequence their full-length cDNAs, and partially characterize
these genes and their recombinant proteins. This paper reports
the identification of 13 additional vertebrate genes closely
related to the spotted seatrout mPR. Structural and phylogenetic
evidence is presented that these vertebrate genes encode for
membrane proteins with seven or occasionally six transmem-
brane domains that can be classified into three subtypes. Hy-
bridization results indicate that the cDNAs of the three subtypes
have different distributions in human tissues. In addition, initial
information on the steroid binding characteristics of three
recombinant proteins representing each of the mammalian
subtypes suggests that they are also mPRs.
Materials and Methods
Identification and Sequence Analysis of Putative mPRs. A BLAST
search of the human genome database was conducted by using
the seatrout mPR coding sequence to identify homologous
human cDNAs. Two human sequence fragments with 54% and
50% amino acid sequence identity to the seatrout mPR were
discovered in the database. These two human genomic sequence
fragments were subsequently used for BLAST searches of EST
databases. Six cDNA clones were identified, two each from
human, mouse, and pig. The identified clones were isolated, fully
sequenced in both directions, and the sequences were deposited
into GenBank (accession nos. AF313615–AF313620). Intrigu-
ingly, two additional cDNA sequences with 29% amino acid
identity to that of seatrout mPR were also identified in human
and mouse databases. Thereafter, we searched for cognate
cDNAs in other vertebrates by using cloning techniques and
database mining. The cDNA sequences of mammals and sea-
trout were used to design degenerate primers to obtain cognate
cDNA sequences from zebrafish and Xenopus (see Supporting
Text, Fig. 6, and Table 2, which are published as supporting
information on the PNAS web site, www.pnas.org). Total RNA
was isolated from ovarian and brain tissues of Xenopus and
zebrafish by using TRIzol extraction reagent (Invitrogen). The
mRNA was isolated from the total RNA with magnetic-oligo
(dT) particles by using a Straight A mRNA Isolation System kit
(Novagen). First-strand synthesis of cDNAs from the polyade-
nylated mRNA was performed by using a GeneRacer kit (In-
vitrogen). Cognate cDNA fragments were amplified from the
synthesized cDNAs by using nested RT-PCR with two sets of
primers. The amplified PCR products were cloned into a TA
cloning vector (Invitrogen) and sequenced in both directions by
using an automated DNA sequencer (Model 310, Perkin–
Elmer). The sequences of the 5 and 3 ends of the cDNAs were
obtained by using 5- and 3-RACE. Finally, the sequences of the
full-length cDNAs were confirmed by using gene-specific prim-
ers based on the sequences of the 5 and 3 ends. Interestingly,
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: mPR, membrane progestin receptor; GPCR, G protein-coupled receptor.
Data deposition: The sequences reported in this paper have been deposited in the GenBank
database (accession nos. AF315615–AF315620 and AY149119–AY1419121).
See commentary on page 2168.
§To whom correspondence should be addressed. E-mail: thomas@utmsi.utexas.edu.
















multiple cognate sequence fragments were also identified from
the Fugu (Japanese pufferfish) genome database.
Structural and Phylogenetic Analysis. Computer analyses [DAS,
HMMTOP, PREDICT PROTEIN, SOSUI (7), TMHMM, TMPRED,
TOPPRED2] were used to predict the likely structure of the protein
and its localization within the cell based on the deduced amino
acid sequence. Multiple sequence alignments for phylogenetic
analyses were constructed by using the PILEUP program of the
Wisconsin Package (Genetics Computer Group, Madison, WI)
based on a progressive alignment method (8). Sequence align-
ments were adjusted manually to minimize gaps with the aid of
MACCLADE V.4.0 (9) to minimize gaps and to avoid introducing
a gap in the middle of a codon. A hypervariable, and thus
unalignable, 11-aa residue region (positions 237–247) was ex-
cluded from the alignments to perform optimal analyses. Phy-
logenetic analyses of the amino acid sequences using parsimony
were conducted by using the computer program PAUP* V.4.0b10
(10). For the aligned 354 amino acid residues, 302 positions are
variable, of which 283 are parsimony-informative. All characters
were treated as unordered and given equal weights. Gaps were
treated as missing characters. Relative branch support was
evaluated by using nonparametric bootstrap (11) and decay
index (12) analyses. Bootstrap values were based on 1,000
pseudoreplicates by using the heuristic search algorithm with the
random stepwise addition of taxa (100 replicates), followed by
tree bisection and reconnection (TBR) branch swapping. Decay
values were computed by using a PAUP* decay index command
file generated by MACCLADE and employing the default heuristic
search strategy with TBR. Amino acid substitutions considered
to be clade-diagnostic were determined by using ACCTRAN
character optimization (13) in PAUP*. Character states optimized
as synapomorphies for clades of interest were then checked
against the data matrix to ensure that they were both invariant
within the clade and absent in all other terminal units.
Northern Blot Analysis. Multiple human tissue expression arrays and
multiple tissue Northern blots were obtained from a commercial
vendor (CLONTECH). Northern hybridization analysis was per-
formed by using a Northern Max Kit (Ambion, Austin, TX).
Receptor probes were prepared by digesting purified plasmids
containing cDNA inserts with appropriate enzymes, and the de-
sired fragments were purified by electrophoresis using low-melting
agarose and a QIAquick Gel Extraction Kit (Qiagen, Chatsworth,
CA). Thereafter, 20–25 ng of DNA were randomly labeled by using
a Pharmacia Rediprime Kit and Amersham Pharmacia Redivue
[-32P]dCTP, and the labeled probe was purified by using a
Pharmacia ProbeQuant G-50 microspin column. The incorporation
rate of [-32P]dCTP ranged from 50% to 80%, and the specific
activity of the probes ranged from 1.2–1.6  109 cpmg. The
membrane was hybridized overnight at 42°C with a labeled probe
at a final concentration of 5  106 cpmml. Nonspecific binding
was stripped off the membrane by washing twice with 20 ml of
low-stringency buffer for 5 min at 42°C and with 20 ml of high-
stringency buffer twice for 15 min at 42°C. The hybridized mem-
brane was exposed to a Kodak Biomax MS film for 3 h to several
days prior to film development.
Expression of Recombinant Protein in BL21(DE3) Escherichia coli cells.
The coding regions of the putative steroid membrane receptors
were amplified by PCR from full-length cDNA plasmid clones.
PCR was carried out in 100-l aliquots containing 50 mM KCl,
10 mM Tris (pH 8.3), 1.5 mM MgCl2, 0.2 mM dNTP, a set of 5
and 3 primers (1 M each), and 2.5 units of TaqDNA poly-
merase mix. After an initial 2-min denaturation at 94°C, the PCR
cycle was repeated five times with denaturation at 94°C for 1 min,
annealing at 50°C for 1 min, and polymerization at 72°C for 2
min. Subsequently, 25 cycles of PCR were carried out under the
same conditions, except annealing, which was conducted at 55°C.
The PCR products were purified by electrophoresis using a
low-melting agarose and a QIAquick Gel Extraction Kit. The
purified PCR products were ligated into a pET-27b expression
vector (Novagen). The pET vector was transformed into
BL21(DE3) E. coli cells. The positive clones were purified and
sequenced. Plasmids without an insert and with a reversed
inserted mPR sequence were used as controls. Expression of
recombinant proteins was induced with isopropyl -D-
thiogalactoside at 25°C. Soluble recombinant proteins were
extracted from whole cells or whole-cell lysates and analyzed for
progestin membrane receptor binding, as described (6).
Results
Phylogenetic and Structural Analyses of Cognate mPRs in Vertebrates.
Thirteen cDNAs similar to the seatrout mPR were identified in
other vertebrate species. Computer structural analyses consis-
tently predicted that all of these cDNAs encoded for plasma
membrane proteins with seven, or occasionally six, transmem-
brane domains. The results of the phylogenetic analysis indicated
that three major clades of mPRs, , , and , exist in two
distantly related vertebrate classes, fishes and mammals (Fig. 1).
The high bootstrap value of 100 strongly supports the divergence
of mPR from the other two groups,  and . The  and  nodes
also have moderate to high bootstrap values of 67 and 83,
respectively. The majority of the nodes in this analysis also have
moderate to high decay support (Fig. 1). Maximum likelihood
analyses (14) of aligned nucleotide sequences are congruent with
the tree reported here (results not shown). There are 8, 16, and
38 amino acid substitutions that characterize and distinguish
the mPR, mPR, and mPR clades, respectively. The ma-
jority of the amino acid residues unique to mPR are in the
extracellular loops (63%, Fig. 2); those diagnostic of mPR are
divided among the N-terminal (20%), transmembrane (40%),
external loops (27%), and internal loops (13%; see Fig. 2
legend), whereas most of those unique to mPR are in the
transmembrane domain (82%, data not shown). The human,
pig, and mouse mPRs have ORFs of 1038–1053 nt, encoding
peptides with 346–350 amino acid residues, similar to the sizes
of the mPRs of spotted seatrout (352 aa) and zebrafish (354
aa). The ORFs of the mammalian, zebrafish, and Xenopus
mPRs (nucleotides 1064–1065; amino acids 352–354) are
Fig. 1. Unrooted phylogenetic tree (single most parsimonious tree, 932
steps; consistency index  0.87; retention index  0.86) showing the three
clades of the putative mPRs. Branch lengths are proportional to the number
of amino acid substitutions and bootstrap values (percentages); decay indexes
are indicated on each branch.
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similar to those of mPR, whereas the mPRs are slightly
shorter (330 aa).
Phylogenetic analyses clearly classify the seatrout mPR into
the  subgroup. Sequence identity comparisons also showed that
seatrout mPR had a higher homology with the  group (Table
1; 52–91% for amino acids, 61–90% for nucleotides) compared
with the  group (Table 1; 46–54% for amino acids, 53–62% for
nucleotides), or  group (25–31% for amino acids, 40–47% for
nucleotides). The transmembrane domains of human mPR and
mPR show high amino acid sequence identities (typically
55–83%) with those of the seatrout mPR (Fig. 3). Several of the
intracellular domains also display high sequence identities with
seatrout mPR, especially those of the -subtype. In contrast,
the homology among extracellular domains is generally lower,
with the exception of the second extracellular loop. Overall,
seatrout mPR shows lower homology to the various domains of
human mPR (Fig. 3). A proposed model for the insertion of the
seatrout membrane progesterone receptor in the plasma mem-
brane based on hydrophobicity and charges of the amino acids
analyzed by SOSUI (7) is shown in Fig. 2. A potential site of
N-linked glycosylation is shown. Most of the transmembrane
domains and portions of the N-terminal end and the large,
second extracellular loops are highly conserved among all of the
putative vertebrate mPRs (shown as solid circles in Fig. 2). The
positions of the eight residues unique to this clade are also shown
(black solid circles).
Tissue Distribution. Dot blot analyses of human multiple tissue
arrays with specific probes for human , , and  showed distinct
Table 1. Percent sequence identity between putative membrane progestin receptors
Fig. 2. Proposed model for insertion of the seatrout putative mPR in the plasma membrane based on hydrophilicity and charges of the amino acid residues
analyzed by SOSUI (8). Each circle represents one amino acid residue. Residues identical in seatrout mPR and the five other vertebrate mPRs are indicated by
the filled colored circles. Amino acid residues diagnostic of this clade are at positions 68 (T), 133 (A), 216 (S), 279 (Q), 310 (Y), 311 (E), 313 (L), and 329 (T) (filled
black circles). Y shows a potential site of N-linked glycosylation, a cysteine residue (C). The proposed models for the mPRs and mPRs are very similar, with large
N-terminal and second extracellular loop domains, and a short C-terminal domain (not shown). Amino acid residues diagnostic of mPR are at positions 6 (L),
11 (T), 22 (L), 89 (V), 102 (L), 114 (L), 138 (S), 167 (S), 203 (R), 204 (P), 205 (Y), 206 (P), 213 (R), 266 (V), 326 (S), 328 (F) from the N-terminal end of human mPR.
















tissue localization of the three forms. The  form (from a
testicular library) was localized in reproductive tissues, particu-
larly in the placenta, testis, ovary, possibly in the uterus and
bladder (Fig. 4a, lane 8), also in the kidney, and possibly in the
adrenal (data not shown). The  form (from a brain library) is
exclusively localized in neural tissues and was detected through-
out the brain and in the spinal cord but not in the pituitary (Fig.
4a, lanes 1–3). The -subtype (from a colon library) is present in
the kidney, fetal kidney, colon, a lung carcinoma, HeLa 53 cells,
and possibly in the adrenal and lung (Fig. 4a, lanes 5–7, 10, 11).
Multiple transcripts of each receptor subtype were detected in
Northern blot analyses. Dot blot analysis does not reveal which
transcript is recognized by the mPR probe. Two  transcripts in
the testis, with a major band at 1.4 kb and a minor one at 2.5 kb,
were detected by Northern blot analysis of multiple tissues (Fig.
4b). The larger (2.5-kb) band was also detected in the ovary,
placenta, and kidney (Fig. 4 b and c). Three  transcripts were
obtained in brain, with a major signal at 5.2 kb and two minor
signals at 3.2 and 2.8 kb (Fig. 4d). A positive signal for  was
detected in the kidney at 5.8 kb (Fig. 4e). It is noteworthy that
tissue distributions of the three human mPR subtypes revealed
by Northern blot analysis are distinct, with significant coexpres-
sion in only a few tissues such as the kidney.
Steroid Binding Characteristics. Recombinant proteins were pro-
duced in the E. coli expression system for each of the three
subtypes. Saturation analyses and Scatchard plots of [3H]pro-
gesterone binding to the recombinant proteins showed the
presence of a single class of high affinity (Kd  28–39 nM),
saturable (Bmax  0.3–0.5 nM) progesterone binding sites for
mouse  mPR (Fig. 5a), human  mPR (Fig. 5b), and human 
mPR (Fig. 5c). The control vector proteins without cDNA inserts
demonstrated no specific binding to [3H]progesterone. Steroid
competition studies with the human  recombinant protein
showed that binding is specific for progesterone and several of
its hydroxylated derivatives, whereas an estrogen, androgen, and
corticosteroid had low or no affinity for the receptor (Fig. 5d).
Several synthetic progestins and antiprogestins also showed no
affinity for the human  protein (Fig. 5e). Association and
dissociation kinetics of [3H]progesterone binding to the human
 protein were rapid, with t1/2 s 2–4 min (Fig. 5f ). These results
demonstrate that the recombinant proteins of mammalian rep-
resentatives of each of the three mPR subtypes have several
binding characteristics typical of steroid receptors.
Discussion
Structural and phylogenetic analyses show the 13 additional
genes identified in other vertebrate species are closely related to
the seatrout mPR described (6) and can be classified into three
subtypes. Computer analyses using a variety of programs that
predict protein structure (DAS, HMMTOP, PREDICT PROTEIN,
SOSUI, TMHMM, TMPRED, TOPPRED2) indicate that all 14 genes
encode proteins that are located in the plasma membrane and
typically have seven transmembrane domains as well as both
extracellular N-terminal and intracellular C-terminal domains.
These protein structures are typical of GPCRs. Although phar-
macological and biological evidence indicates that seatrout
mPR activates an inhibitory G protein and, therefore, may be
a GPCR (6), equivalent information is currently lacking for the
other members of this protein family. However, the results of the
present study clearly show that three mammalian genes, repre-
senting each of the three subtypes, encode proteins with binding
characteristics typical of progestin membrane receptors. High
affinity, saturable, single binding sites for progesterone can be
demonstrated with the human , mouse , and human 
recombinant proteins produced in an E. coli expression system.
Additional studies with the human  protein show that steroid
binding is specific for progestins and is readily displaceable.
Moreover, the kinetics of association and dissociation are rapid,
occurring within a few minutes, which is typical of steroid
membrane receptors. Interestingly, several synthetic progestins
and antiprogestins, which have relatively high binding affinities
for nuclear progesterone receptors, display no binding affinity
for the recombinant human  protein. Lack of binding of
synthetic progestins and antiprogestins to progestin membrane
receptors has also been observed in biochemical binding studies
(15). Finally, the human , , and  transcripts are localized to
specific tissues that are known targets of nongenomic proges-
terone actions in mammals (4, 16–18). Taken together, these
results suggest that this is a hitherto unknown family of progestin
membrane receptors that are unrelated to nuclear progesterone
receptors.
The presence of the -, - and -subtypes both in a fish species,
Fugu, and in several mammalian species, suggests they arose
early in vertebrate evolution, before the divergence of the
Fig. 3. Amino acid sequence comparison between seatrout mPR and the
three putative human mPRs. Numbers above the box indicate percent se-
quence identity of amino acids in each domain between the fish mPR and
human putative mPRs. Extracellular, solid gray; transmembrane, solid black;
cytoplasmic domains, white.
Fig. 4. (a) Dot blot hybridization of human mPR  (testicular),  (brain), and
 (kidney) mRNA probes with human multiple tissue arrays (CLONTECH). Only
lanes displaying strong hybridizations with each of the probes are shown.
Lanes 1–3 (various regions of CNS): b1 and g1, cerebral cortex; a2 and b2,
cerebellum; e2, caudate nucleus; c3, thalamus; d3, pituitary gland; e3, spinal
cord. Lane 4: regions of heart. Lanes 5 and 6 (gastrointestinal tract): h5, a6, and
b6, colon. Lane 7 (kidney, hemopoietic, and lymphatic tissues): a7, kidney.
Lane 8 (reproductive tissues): b8, placenta; d8, uterus; f8, testis; g8, ovary. Lane
9: liver and endocrine glands. Lane 10: lymphomas and carcinomas. Lane 11
(fetal tissues): c11, fetal kidney. (b–e) Northern hybridization of human , ,
and  mRNA probes with human multiple tissue Northern blots (CLONTECH).
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ray-finned (Actinopterygian) and lobe-finned (Sarcopterygian)
fishes in the lower Devonian period, 400 million years ago (19).
Information for hagfishes and lampreys may indicate whether
the three subtypes could have arisen from a common ancestral
gene by duplication during an earlier period of vertebrate
evolution. Several such gene duplications have been proposed
for nuclear steroid receptors based on the results of previous
genetic analyses in these basal vertebrates (20, 21). One such
duplication event in the Actinopterygian lineage, 200 million
years ago (22), probably accounts for the presence of two
paralogs of the ancestral nuclear estrogen receptor  gene in
extant euteleosts (23). However, the similar branch lengths
separating the three subtypes does not suggest further duplica-
tion and preservation of any of the mPR genes. The overall
percent nucleotide and amino acid sequence identities among
the vertebrate species for each of the putative mPR subtypes
reflect their phylogenetic relationships, the phylogram showing
the expected separate branches for the teleost and mammalian
representatives of each subtype and the euteleost s further
branching into the Acanthopterygii (Fugu and spotted seatrout)
and Ostariophysi (zebrafish). Interestingly, there is a marked
divergence of the Fugu and mammalian mPRs that may indicate
modified functions within this subtype. More detailed compar-
isons of the sequence identities of various regions of the putative
mPRs may be mented when information on their functional
domains becomes available.
An interesting finding was that the Northern and dot blot
hybridization analyses showed different tissue distributions for
the mRNAs of the three human mPR subtypes, with only the
kidney expressing more than one subtype in significant amounts.
In contrast, multiple subtypes of nuclear steroid receptors are
present in the brain and gonads and have overlapping distribu-
tions in certain regions (23, 24) and, therefore, have the potential
to form heterodimers. GPCRs also form dimers that may be
important for receptor activation (25, 26). However, the forma-
tion of heterodimers among the mPR subtypes is unlikely in most
human tissues based on the distributions of their mRNAs. The
significance of the distinct distributions of the three mPR
subtypes in humans is unclear. One possible explanation for the
apparent exclusive localization of the human mPR mRNA in
neural tissues is that this subtype is characteristic of tissues of
ectodermal origin. However, the mouse mPR was cloned from
a testicular cDNA library, which suggests this subtype also occurs
in tissues of mesodermal origin. Conversely, mouse mPR was
cloned from a brain cDNA library, which suggests that this
subtype is also present in the brains of certain mammals. The low
transcript levels of the -subtype detected in the brains of
spotted seatrout (6) are a further indication that mPR may be
involved in some cell surface–initiated progesterone actions in
the vertebrate brain.
The distinct, nonoverlapping tissue distributions of the
mRNAs of the human mPR and - subtypes indicate they
regulate different physiological functions of progesterone. The
presence of significant transcript levels of mPR in the human
testis, ovary, and placenta suggests it is the major subtype
mediating the rapid, nongenomic actions of progesterone in
reproductive tissues. There is considerable evidence that pro-
gesterone has rapid actions on human sperm to induce hyper-
activity and the acrosome reaction by binding to an mPR (27, 28).
Similarly, an mPR previously characterized biochemically on
sperm in spotted seatrout is likely the intermediary in the rapid
actions of progestins to increase sperm motility and fertilization
success in this species (29). The finding that the mPR protein
is localized on seatrout sperm membranes suggests that it may be
the mediator of this effect (6). Therefore, the mPR is also a
candidate, among others (30, 31), for the protein receptor
involved in the rapid progesterone actions on mammalian sperm.
Interestingly, subfertility and oligospermia in men have been
Fig. 5. Steroid binding characteristics of recombinant mammalian proteins produced in E. coli. Saturation (a–c Insets) and Scatchard analyses of [3H]proges-
terone binding to recombinant mouse  (a), human  (b), and human  (c) proteins. (d) Competition curves of steroid binding to the recombinant human mPR
protein. Binding is expressed as a percentage of maximum specific binding. P4, progesterone; 17-P, 17-hydroxyprogesterone; 20b-P, 20-hydroxyprogesterone;
E2, estradiol-17; T, testosterone; F, cortisol; RU486, synthetic antiprogestin. (e) Competition curves of binding of synthetic antihormones to the recombinant
human mPRprotein. Vit D: 1, 25(OH)-vitamin D. Antiprogestins: ZK9, ZK98299; ZK1, ZK112983; ORG, ORG31710. Antiandrogen: Cim, cimetidine. Antiestrogen:
ICI, ICI182,780. ( f) Time course of association and dissociation of specific progesterone binding to human mPR.
















associated with reduced responses to progesterone and de-
creased concentrations of the mPR (32–34). Thus, the human
mPR has potential medical significance in the diagnosis of male
subfertility and as a target for a new generation of fertility drugs
and contraceptives. Currently, evidence that mPRs have equiv-
alent functions in female gametes in mammals is lacking. Al-
though important roles for progestins and mPRs in the induction
of meiotic maturation of oocytes have been clearly demonstrated
in teleosts (35), there is no clear evidence progesterone may have
similar functions in mammals. However, nongenomic progester-
one actions and the presence of specific binding sites have been
reported in the corpus luteum of mammals, which suggests
mPR may be involved in other ovarian functions controlled by
somatic cells (17). Similarly, progesterone has been shown to
bind to a specific mPR on Leydig cells in the testis to stimulate
sodium influx and steroidogenesis (16). Nongenomic actions of
progesterone have also been reported in several regions of the
brain, including the hypothalamus (regulating LHRH secretion)
and the ventral tegmental area (influencing sexual receptivity in
rodents) (36, 37). The fact that one of the subtypes is present in
the brain provides the first indication that progesterone and its
metabolites may also exert nongenomic actions via specific
mPR receptors, in addition to binding to modulatory sites on
neurotransmitter receptors, such as the GABAabenzodiazepine
receptor Cl channel complex (38, 39). There is currently less
evidence for nongenomic actions of progesterone in tissues with
significant transcript levels of mPR. However, progesterone has
been shown to exert rapid, nongenomic actions in intestinal
tissues, resulting in a reduction in smooth muscle calcium
currents and, in renal cells, in an alteration of potassium
conductance (18, 40). A variety of environmental toxicants could
also potentially interfere with the nongenomic actions of pro-
gesterone in these target tissues in mammals by binding to their
mPRs. This mechanism of endocrine disruption has previously
been demonstrated for mPR on the oocytes and sperm of
spotted seatrout and a closely related species, Atlantic croaker,
after exposure to organochlorines such as DDT that have
estrogenic activities (41, 42).
The discovery of the molecular structure and likely orientation
in the plasma membrane of a new class of steroid receptors,
unrelated to nuclear receptors but, instead, characteristic of
GPCRs, provides a plausible mechanistic explanation of how
steroids acting at the cell surface can cause rapid intracellular
responses. An understanding of the mechanism of nonclassical
steroid action mediated by these receptors will provide a sound
molecular basis for future studies in this emerging field of
endocrinology. It will also enable investigations of the integra-
tion of rapid, nongenomic, and slower genomic responses to
steroid hormones in target cells.
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